- Get link
- X
- Other Apps
President Donald J. Trump signed an executive order to accelerate access to treatments for patients with serious mental illness, including psychedelics. The order directs the FDA to provide National Priority Vouchers to psychedelic drugs with Breakthrough Therapy designations, ensuring a streamlined review process. It also allocates $50 million through the Advanced Research Projects for Health (ARPAH) program to support state investments in psychedelic research. The order aims to increase clinical trial participation and generate evidence ...